Nitric oxide synthase inhibitors attenuate transforming-growth-factor- β1-stimulated capillary organization in vitro

American Journal of Pathology

Volumn 150, Issue 5, 1997, Pages 1835-1844

  Papapetropoulos, Andreas ^a   Desai, Kaushik M ^a   Rudic, R Daniel ^a   Mayer, Bernd ^c   Zhang, Rong ^a   Ruiz Torres, Maria P ^d   García Cardeña, Guillermo ^a   Madri, Joseph A ^b   Sessa, William C ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Karl Franzens Uhiversitat Graz   (Austria)

^d UNIVERSITY OF ALCALÁ   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; TRANSFORMING GROWTH FACTOR BETA1;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CAPILLARY; CELL DIFFERENTIATION; CELL MIGRATION; CELL PROLIFERATION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; VASCULAR ENDOTHELIUM;

ADIPOSE TISSUE; ANIMALS; CAPILLARIES; CELL DIFFERENTIATION; CELL DIVISION; CELLS, CULTURED; COLLAGEN; ENDOTHELIUM, VASCULAR; EPIDIDYMIS; GELS; MALE; NEOVASCULARIZATION, PHYSIOLOGIC; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; RATS; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030901666     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (54)

1. Folkman J, Klagsburn M: Angiogenic factors. Science 1987, 235:442-447
2. Folkman J, Shing Y: Angiogenesis. J Biol Chem 1992, 267:10931-10933
3. Fidler IJ, Ellis LM: The implications of angiogenesis for the biology and therapy of cancer metastasis (Comment), Cell 1994, 79:185-188
4. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995, 1:27-31
5. Gerritsen ME, Shen C-P, Atkinson WJ, Padgett RC, Gimbrone MA Jr, Milstone DS: Microvascular endothelial cells from E-selectin-deficient mice form tubes in vitro. Lab Invest 1996, 75:175-184
6. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK: Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989, 58:933-943
7. Merwin JR, Anderson JM, Kocher O, Van Itallie CM, Madri JA: Transforming growth factor β1 modulates extracellular matrix organization and cell-cell junctional complex formation during in vitro angiogenesis. J Cell Physiol 1990, 142:117-128
8. Nehls V, Drenckhahn D: A novel, microcarrier-based in vitro assay for rapid and reliable quantification of three-dimensional cell migration and angiogenesis. Microvasc Res 1995, 50:311-322
9. Marx M, Perlmutter RA, Madri JA: Modulation of platelet-derived growth factor receptor expression in micro-vascular endothelial cells during in vitro angiogenesis. J Clin Invest 1994 ,93:131-139
10. Sankar S, Mahooti-Brooks N, Bensen L, McCarthy TL, Centrella M, Madri JA: Modulation of transforming growth factor β receptor levels on microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1996, 97:1436-1446
11. Madri JA, Bell L, Marx M, Merwin JR, Basson C, Prinz C: Effects of soluble factors and extracellular matrix components on vascular cell behavior in vitro and in vivo: models of de-endothelialization and repair. J Cell Biochem 1991, 45:123-130
12. Forstermann U, Closs EI, Pollock JS, Nakani M, Schwarz P, Gath I, Kleinert H: Nitric oxide synthase isozymes. Characterization, purification, molecular cloning and functions. Hypertension 1994, 23:1121-1131
13. Moncada S, Palmer RMJ, Higgs EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43:109-142
14. Sessa WC: The nitric oxide synthase family of proteins. J Vasc Res 1994, 31:131-143
15. Kourembanas S, McQuillan LP, Leung GK, Faller DV: Nitric oxide regulates the expression of vasoconstrictors and growth factors by vascular endothelium under both normoxia and hypoxia. J Clin Invest 1993, 92:99-104
16. Draijer R, Atsma DE, van der Laarse A, van Hinsbergh VW: cGMP and nitric oxide modulate thrombin-induced endothelial permeability. Regulation via different pathways in human aortic and umbilical vein endothelial cells. Circ Res 1995, 76:199-208
17. Trachtman H, Futterweit S, Garg P, Reddy K, Singhal PC: Nitric oxide stimulates the activity of a 72-kDa neutral matrix metalloproteinase in cultured rat mesangial cells. Biochem Biophys Res Commun 1996, 218: 704-708
18. Murrell GA, Sang D, Williams RJ: Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem Biophys Res Commun 1995, 206:15-21
19. Morbidelli L, Chang C-H, Douglas JG, Granger HJ, Ledda F, Ziche M: Nitric oxide mediates mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol 1996, 270:H411-H415
20. Ziche M, Morbidelli L, Masini E, Amerini S, Granger HJ, Maggi CA, Geppetti P, Ledda F: Nitric oxide mediates angiogenesis in vivo and endothelial cell growth and migration in vitro promoted by substance P. J Clin Invest 1994, 94:2036-2044
21. Peunova N, Enikolopov G: Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cells. Nature 1995, 375:68-73
22. Pipili-Synetos E, Sakkoula E, Haralabopoulos G, Andriopoulou P, Peristeris P, Maragoudakis ME: Evidence that nitric oxide is an endogenous antiangiogenic mediator. Br J Pharmacol 1994, 111:894-902
23. Pipili-Synetos E, Papageorgiou A, Sakkoula E, Sotiropoulou G, Fotsis T, Karakiulakis G, Maragoudakis ME: Inhibition of angiogenesis, tumour growth and metastasis by the NO-releasing vasodilators, isosorbide mononitrate and dinitrate. Br J Pharmacol 1995, 116: 1829-1834
24. Madri JA, Williams SK: Capillary endothelial cell cultures: phenotypic modulation by matrix components. J Cell Biol 1983, 97:153-165
25. Form DM, Pratt BM, Madri JA: Endothelial cell proliferation during angiogenesis. In vitro modulation by basement membrane components. Lab Invest 1986, 55: 521-530
26. Madri JA, Furthmayr H: Collagen polymorphism in the lung. An immunochemical study of pulmonary fibrosis. Hum Pathol 1980, 11:353-366
27. Mohaupt MG, Madsen KM, Wilcox CS, Clapp W, Kone BC: Molecular characterization and localization of three nitric oxide synthase isoforms in rat kidney. The biology of nitric oxide. Enzymology, Biochemistry and Immunology. London, Porland Press, 1994, pp 137-142
28. Nunokawa Y, Ishida N, Tanaka S: Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. Biochem Biophys Res Commun 1993, 191:89-94
29. Bredt DS, Hwang PM, Glatt CE, Lowenstein C, Reed RR, Snyder SH: Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase, Nature 1991, 351:714-718
30. Geng YJ, Almqvist M, Hansson GK: cDNA cloning and expression of inducible nitric oxide synthase from rat vascular smooth muscle cells. Biochim Biophys Acta 1994, 1218:421-424
31. Liu J, Sessa WC: Identification of covalently bound amino-terminal myristic acid in endothelial nitric oxide synthase. J Biol Chem 1994, 269:11691-11694
32. 2+/calmodulin-dependent cytochrome c reductase activity of brain nitric oxide synthase, J Biol Chem 1992, 267:11374-11378
33. Madri JA, Pratt BM, Tucker AM: Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organization of the extracellular matrix. J Cell Biol 1988, 106:1375-1384
34. Southan GJ, Szabo C, Thiemermann C: Isothioureas: potent inhibitors of nitric oxide syntheses with variable isoform selectivity. Br J Pharmacol 1995, 114:510-516
35. Konturek SJ, Brzozowski T, Majka J, Pytko-Polonczyk J, Stachura J: Inhibition of nitric oxide synthase delays healing of chronic gastric ulcers. Eur J Pharmacol 1993, 239:215-217
36. Andrade SP, Hart IR, Piper PJ: Inhibitors of nitric oxide synthase selectively reduce flow in tumor-associated neovasculature, Br J Pharmacol 1992, 107:1092-1095
37. Ku DD, Zaleski JK, Liu S, Brock TA: Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries, Am J Physiol 1993, 265:H586-H592
38. Leibovich SJ, Polverini PJ, Fong TW, Harlow LA, Koch AE: Production of angiogenic activity by human monocytes requires an L-arginine/nitric oxide-synthase-dependent effector mechanism. Proc Natl Acad Sci USA 1994, 91:4190-4194
39. Jenkins DC, Charles IG, Thomsen LL, Moss DW, Holmes LS, Baylis SA, Rhodes P, Westmore K, Emson PC, Moncada S: Roles of nitric oxide in tumor growth. Proc Natl Acad Sci USA 1995, 92:4392-4396
40. MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, Trumbauer M, Stevens K, Xie QW, Sokol K, Hutchinson N, Chen H, Mudgett JS: Altered responses to bacterial infection and endotoxic shock in mice lacking inducible nitric oxide synthase. Cell 1995, 81:641-650 (Erratum 81:1170)
41. Laubach VE, Shesely EG, Smithies O, Sherman PA: Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc Natl Acad Sci USA 1995, 92:10688-10692
42. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, Xu D, Muller W, Moncada S, Liew FY: Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 1995, 375:408-411
43. Huang PL, Dawson TM, Bredt DS, Snyder SH, Fishman MC: Targeted disruption of the neuronal nitric oxide synthase gene. Cell 1993, 75:1273-1286
44. Huang PL, Huang Z, Mashimo H, Bloch KD, Moskowitz MA, Bevan JA, Fishman MC: Hypertension in mice lacking the gene for endothelial nitric oxide synthase. Nature 1995, 377:239-242
45. Inoue N, Venema RC, Sayegh HS, Ohara Y, Murphy TJ, Harrison DG: Molecular regulation of the bovine endothelial nitric oxide synthase by transforming growth factor-β1. Arterioscler Thromb Vasc Biol 1995, 1255-1261
46. Forstermann U, Kleinert H, Gath I, Schwarz P, Closs EI, Dun NJ: Expression and expressional control of nitric oxide syntheses in various cell types. Adv Pharmacol 1995, 34:171-186
47. Akarasereenont P, Bakhle YS, Thiemermann C, Vane JR: Cytokine-mediated induction of cyclo-oxygenase-2 by activation of tyrosine kinase in bovine endothelial cells stimulated by bacterial lipopolysaccharide. Br J Pharmacol 1995, 115:401-408
48. Guo FH, De Raeve HR, Rice TW, Stuehr DJ, Thunnissen FB, Erzurum SC: Continuous nitric oxide synthesis by inducible nitric oxide synthase in normal human airway epithelium in vivo. Proc Natl Acad Sci USA 1995, 92:7809-7813
49. Kumar M, Liu GJ, Floyd RA, Grammas P: Anoxic injury of endothelial cells increases production of nitric oxide and hydroxyl radicals. Biochem Biophys Res Commun 1996, 219:497-501
50. Fujisawa H, Ogura T, Kurashima Y, Yokoyama T, Yamashita J, Esumi H: Expression of two types of nitric oxide synthase mRNA in human neuroblastoma cell lines. J Neurochem 1994, 63:140-145
51. García-Cardeña G, Oh P, Liu J, Schnitzer JE, Sessa WC: Targeting of nitric oxide synthase to endothelial cell caveolae via palmitylation: implications for nitric oxide signaling, Proc Natl Acad Sci USA 1996, 93: 6448-6453
52. Li S, Okamoto T, Chun M, Sargiacomo M, Casanova JE, Hansen SH, Nishimoto I, Lisanti MP: Evidence for a regulated interaction between heterotrimeric G proteins and caveolin. J Biol Chem 1995, 270:15693-15701
53. Liu P, Ying Y, Ko Y-G, Anderson RGW: Localization of platelet-derived growth factor-stimulated phosphorylation cascade in caveolae. J Biol Chem 1996, 271: 10299-10303
54. Liu J, García-Cardeña G, Sessa WC: Palmitoylation of endothelial nitric oxide synthase is necessary for optimal stimulated release of nitric oxide: implications for caveolae localization. Biochemistry 1996, 35:13277-13281